State newborn‑screening advisory panel votes against adding 3MCC

Dec 9, 2025

After presentations, family testimony and criterion‑by‑criterion discussion, the Newborn Screening Technical Advisory Committee voted 13–0 (with one member deferring) against recommending adding 3‑Methylcrotonyl‑CoA carboxylase deficiency (3MCC) to Washington’s newborn screening panel.

The full story

The Newborn Screening Technical Advisory Committee (TAC) voted on Dec. 9, 2025 not to recommend adding 3‑Methylcrotonyl‑CoA carboxylase deficiency (3MCC) to Washington’s newborn screening panel.